Identification of the feline herpesvirus type 1 (FHV-1) genes encoding glycoproteins G, D, I and E: expression of FHV-1 glycoprotein D in vaccinia and raccoon poxviruses

References

1. Audonnet J.-C., Winslow J., Allen G., Paoletti E. 1990; Equine herpesvirus type I unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gl and gE. Journal of General Virology 71:2969–2978
   [Google Scholar]
2. Ausubel F., Brent R., Kingston R., Moore D., Seidman J., Smith J., Struhl K. 1988 Current Protocols in Molecular Biology New York: John Wiley and Sons;
   [Google Scholar]
3. Bell C. W., Boyle D. B., Whalley J. M. 1990; Transcript analysis of the equine herpesvirus 1 glycoprotein B gene homologue and its expression by a recombinant vaccinia virus. Journal of General Virology 71:1119–1129
   [Google Scholar]
4. Birnstiel M., Busslinger M., Strub K. 1985; . Transcription termination and 3ʹ processing: the end is in site! Cell 41:349–359
   [Google Scholar]
5. Blacklaws B. A., Nash A. A., Darby G. 1987; Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines. Journal of General Virology 68:1103–1114
   [Google Scholar]
6. Blacklaws B., Minson T., Nash A. 1990; Immunogenicity of herpes simplex virus type 1 glycoprotein expressed in vaccinia virus recombinants. Virology 111:727–736
   [Google Scholar]
7. Britt W., Vugler L., Butfiloski E., Stephens E. 1990; Cell surface expression of human cytomegalovirus (HCMV) gp55-116: use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. Journal of Virology 64:1079–1085
   [Google Scholar]
8. Cantin E., Eberle R., Baldick J., Moss B., Willey D., Notkins A., Openshaw H. 1987; Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proceedings of the National Academy of Sciences U.S.A.: 845908–5912
   [Google Scholar]
9. Corden J., Wasylyk B., Buchwalder A., Sassone-Corsi P., Kedinger C., Chambon P. 1980; Promoter sequences of eukaryotic protein-coding genes. Science 209:1406–1414
   [Google Scholar]
10. Courtney R. 1991; Membrane-associated antigens of herpes simplex virus. Reviews of Infectious Diseases 13:917–920
    [Google Scholar]
11. Crandell R., Maurer F. 1958; Isolation of a feline virus associated with intranuclear inclusion bodies. Proceedings of the Society for Experimental Biology and Medicine 97:487–190
    [Google Scholar]
12. Cremer K., Mackett M., Wohlenberg C., Notkins A., Moss B. 1985; Vaccinia virus recombinants expressing herpes simplex virus type 1 glycoprotein D prevent latent herpes in mice. Science 228:737–740
    [Google Scholar]
13. Davison A. J. 1984; DNA sequence of the U_scomponent of the varicella-zoster virus genome. EMBO Journal 12:2203–2209
    [Google Scholar]
14. Devereux J., Haeberli P., Smithies O. 1984; A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research 12:387–395
    [Google Scholar]
15. Ditchfield J., Grinyer I. 1965; Feline rhinotracheitis virus: a feline herpesvirus. Virology 26:504–506
    [Google Scholar]
16. Eberle R., Mou S., Zaia J. 1985; The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections. Journal of Medical Virology 16:147–162
    [Google Scholar]
17. Eisenberg R., Cerini C., Heilman C., Joseph A., Dietzschold B., Golub E., Long D., Ponce De Leon M., Cohen G. 1985; Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. Journal of Virology 56:1014–1017
    [Google Scholar]
18. Eloit M., Gilardi-Herbenstreit P., Toma B., Perricaudet M. 1990; Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. Journal of General Virology 71:2425–2431
    [Google Scholar]
19. Elton D. M., Bonass W. A., Killington R. A., Meredith D. M., Halliburton I. W. 1991; Location of open reading frames coding for equine herpesvirus type-1 glycoproteins with homology to gE and gl of herpes simples virus. American Journal of Veterinary Research 52:1252–1257
    [Google Scholar]
20. Esposito J., Knight J., Shaddock J., Novembre F., Baer G. 1988; Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein. Virology 165:313–316
    [Google Scholar]
21. Fargeaud D., Benoit-Jeannin C., Kato F., Chappuis G. 1984; Biochemical study of the feline herpesvirus 1. Archives of Virology 80:69–82
    [Google Scholar]
22. Flowers C., O’Callaghan D. 1992; The equine herpesvirus type 1 (EHV-1) homolog of herpes simplex virus type 1 U_s9 and the nature of a major deletion within the unique short segment of the EHV-1 KyA strain genome. Virology 190:307–315
    [Google Scholar]
23. Flowers C., Eastman E., O’Callaghan D. 1991; Sequence analysis of a glycoprotein D gene homolog within the unique short segment of the EHV-1 genome. Virology 180:175–184
    [Google Scholar]
24. Fuller A., Lee W. 1992; Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. Journal of Virology 66:5002–5012
    [Google Scholar]
25. Hanke T., Graham F., Rosenthal K., Johnson D. 1991; Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. Journal of Virology 65:1177–1186
    [Google Scholar]
26. Horimoto T., Limcumpao A., Tohya Y., Takahashi E., Mikami T. 1990; Feline herpesvirus type 1 glycoprotein eliciting virus neutralizing and hemagglutination-inhibiting antibodies. Archives of Virology 111:127–132
    [Google Scholar]
27. Johnson D. 1991; Adenovirus vectors as potential vaccine against herpes simplex virus. Reviews of Infectious Diseases 13:912–916
    [Google Scholar]
28. Klenk H., Rott R. 1980; Co-translational and post-translation processing of viral glycoproteins. Current Topics in Microbiology and Immunology 90:19–18
    [Google Scholar]
29. Knight J., Goldsmith C., Tamin A., Regnery R., Regnery D., Esposito J. 1992; Further analyses of the Orthopoxviruses volepox virus and raccoon poxvirus. Virology 190:423–433
    [Google Scholar]
30. Kozak M. 1986; Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283–292
    [Google Scholar]
31. Kyte J., Doolittle R. F. 1982; A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 157:105–132
    [Google Scholar]
32. Limcumpoa J., Horimoto T., Xuan X., Takahashi E., Mikami T. 1990; Immunological relationship between feline herpesvirus type 1 (FHV-1) and canine herpesvirus (CHV) as revealed by polyvalent and monoclonal antibodies. Archives of Virology 11:165–176
    [Google Scholar]
33. Long D., Madara T., Ponce De Leon M., Cohen G., Montgomery P., Eisenberg R. 1984; Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infection and Immunity 37:761–764
    [Google Scholar]
34. McDermott M., Graham F., Hanke T., Johnson D. 1989; Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology 169:244–247
    [Google Scholar]
35. McGeoch D. J., Dolan A., Donald S., Rixon F. J. 1985; Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. Journal of Molecular Biology 181:1–13
    [Google Scholar]
36. Maes R., Fritsch S., Herr L., Rota P. 1984; Immunogenic proteins of feline rhinotracheitis virus. Journal of Virology 51:259–262
    [Google Scholar]
37. Marchioli C., Yancey R., Petrovskis E., Timmins J., Post L. 1987; Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky’s disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells. Journal of Virology 61:3977–3982
    [Google Scholar]
38. Moss B., Flexner C. 1987; Vaccinia virus expression vectors. Annual Review of Immunology 5:305–324
    [Google Scholar]
39. Pereira L., Ali M., Kousoulas K., Huo B., Banks T. 1989; Domain structure of herpes simplex virus type 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology 172:11–24
    [Google Scholar]
40. Petrovskis E. A., Timmins J. G., Armentrout M. A., Marchioli C. C., Yancey R. J., Post L. E. 1986; DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without TV-linked glycosylation. Journal of Virology 70:417–427
    [Google Scholar]
41. Povey R. 1979; A review of feline viral rhinotracheitis (feline herpesvirus 1 infection). Comparative Immunology, Microbiology and Infectious Diseases 2:373–387
    [Google Scholar]
42. Rixon F. J., McGeoch D. J. 1985; Detailed analysis of the mRNAs mapping in the short unique region of herpes simplex virus type 1. Nucleic Acid Research 13:953–973
    [Google Scholar]
43. Rooney J., Wohlenberg C., Cremer K., Moss B., Notkins A. 1988; Immunization with a vaccina virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. Journal of Virology 62:1530–1534
    [Google Scholar]
44. Ross L. J. N., Binns M. M. 1991; Properties and evolutionary relationships of the Marek’s disease virus homologues of protein kinase, glycoprotein D and glycoprotein I of herpes simplex virus. Journal of General Virology 72:939–947
    [Google Scholar]
45. Rota P., Maes R., Ruyechan W. 1986; Physical characterization of the genome of feline herpesvirus-1. Virology 54:168–179
    [Google Scholar]
46. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn.. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
47. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences U.S.A.: 745463–5467
    [Google Scholar]
48. Scott F. 1988; Raccoon poxvirus in the cat - candidate carrier virus for recombinant vaccines. In Proceedings of the 69th Conference of Research Workers in Animal Disease, Chicago, Illinois U.S.A.: p 60
    [Google Scholar]
49. Talens L. T., Zee Y. 1976; Purification and buoyant density of infectious bovine rhinotracheitis virus. Proceedings of the Society for Experimental Biology and Medicine 151:132–135
    [Google Scholar]
50. Telford E. A. R., Watson M. S., McBride K., Davison A. J. 1992; The DNA sequence of equine herpesvirus-1. Virology 189:304–316
    [Google Scholar]
51. Tham K., Studdert M. 1987; Clinical and immunological responses of cats to feline herpes type 1 infection. Veterinary Record 120:321–326
    [Google Scholar]
52. Van Zijl M., Van Der Gulden H., De Wind N., Glelkens A., Berns A. 1990; Identification of two genes in the unique short region of pseudorabies virus; comparison with herpes simplex virus and varicella-zoster virus. Journal of General Virology 71:1747–1755
    [Google Scholar]
53. Von Heijne G. 1986; A new method for predicting signal sequence cleavage sites. Nucleic Acids Research 14:4683–1690
    [Google Scholar]
54. Wachsman M., Luo J. H., Aurelian L., Perkus M. E., Paoletti E. 1989; Antigenic-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunity. Journal of General Virology 70:2513–2520
    [Google Scholar]
55. Wagner E. 1983; Transcription pattern in HSV infections. In Advances in Viral Oncology 3 pp 239–270 Klein G. Edited by New York: Raven Press;
    [Google Scholar]
56. Yanagida N., Ogawa R., Li Y., Lee L., Nazerian K. 1992; Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 of Marek’s disease virus. Journal of Virology 66:1402–1408
    [Google Scholar]